Study: Inadequate vitamin B12 in seniors could be linked to cognitive decline
BOSTON — Being mildly vitamin B-12 deficient could be an indication that some older adults are at a greater risk for accelerated cognitive decline, according to an observational study from researchers at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University released Wednesday.
Lead researcher Martha Savaria Morris of the Nutrition Epidemiology Program at the HNRCA examined data from 549 men and women enrolled in a cohort of the Framingham Heart Study, focusing on scores on the Mini-Mental State Examination, a short list of questions and tasks commonly used to screen for dementia. The subjects were divided into five groups, based on their vitamin B-12 blood levels.
Being in the two lowest groups was associated with significantly accelerated cognitive decline, based on an analysis of test scores from five MMSE tests given over a period of eight years.
“Men and women in the second lowest group did not fare any better in terms of cognitive decline than those with the worst vitamin B-12 blood levels. Over time, their MMSE scores declined just as rapidly,” Morris said. “Rapid neuropsychiatric decline is a well-known consequence of severe vitamin B-12 deficiency, but our findings suggest that adverse cognitive effects of low vitamin B-12 status may affect a much larger proportion of seniors than previously thought.”
“While we emphasize our study does not show causation, our associations raise the concern that some cognitive decline may be the result of inadequate vitamin B-12 in older adults, for whom maintaining normal blood levels can be a challenge,” stated Paul Jacques, the study’s senior author and director of the Nutrition Epidemiology Program.
Play Beverages pulls out of bankruptcy court to protect Playboy Energy Drink license
SALT LAKE CITY — Play Beverages on Friday announced that the U.S. Bankruptcy Court for the District of Utah has ruled in its favor and vacated its bankruptcy, freeing it to take legal actions to protect the product license granted for its Playboy Energy Drink.
The judge’s ruling takes Play Beverages out of an involuntary bankruptcy, enabling it to continue its action in state courts against Playboy Enterprises and others to protect its license to produce and sell Playboy Energy Drink.
“The ruling by Judge Marker to take Play Beverages out of bankruptcy, allowing the resumption of normal business activities, is the end of a nightmare,” stated Iehab Hawatmeh, president CirTran Beverages. CirTran Beverages had partnered with Play Beverages to introduce and distribute the Playboy Energy Drink. “Now, after 18 months of seeing every aspect of our business impacted negatively, we can move forward to hopefully regain our momentum and resume growing our beverage business.”
Meda expands OTC portfolio with MidNite sleep aid acquisition
SOLNA, Sweden — Meda announced Friday that it has signed an agreement to acquire MidNite, an OTC sleep-aid product. MidNite is well established in the U.S. and holds a market leading position within a growing category. Transaction terms were not disclosed.
“This acquisition enhances our presence in the U.S. ahead of other future OTC launches," stated Anders Lönner, CEO of Meda.
Annualized revenues for MidNite are approximately $15 million, the company reported.